Skip to content
Hi-Doctor

How to Get Retatrutide Online in The Hague

Looking for Retatrutide online in The Hague? While this promising new peptide is generating buzz, it's not yet approved for prescription in the EU.

23 April 2026
How to Get Retatrutide Online in The Hague

How to Get Retatrutide Online in The Hague

If you're searching for Retatrutide online in The Hague, it's important to understand its current status. Retatrutide is a highly anticipated experimental treatment, but it is not currently approved for weight-loss prescription in the European Union, meaning Hi-Doctor does not offer it. This article will explain what Retatrutide is, why it's not a standard option yet, and critically, what proven, EU-approved weight-loss treatments you CAN access today from an EU-licensed doctor.

What is Retatrutide, and why isn't it a normal option yet?

Retatrutide is an investigational drug that acts as a triple agonist, targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This multi-faceted approach aims to achieve significant weight loss and improve metabolic health. While early clinical trial results have been very promising, Retatrutide is still in late-stage clinical development. The European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) have not yet granted it marketing authorisation for weight management. This means it is not legally available for prescription in the EU. Attempting to purchase Retatrutide from unregulated online sources or 'research chemical' vendors carries significant health risks, as these products may be counterfeit, impure, or incorrectly dosed, with no medical oversight.

Proven weight-loss medications available online today

While Retatrutide is still in development, several highly effective and EU-approved medications are available for weight management, prescribed by licensed doctors.

  • Ozempic (semaglutide): A GLP-1 receptor agonist, often prescribed for type 2 diabetes but also effective for weight loss. It works by reducing appetite and slowing gastric emptying.
  • Wegovy (semaglutide, higher-dose): This is the higher-dose version of semaglutide, specifically approved and indicated for chronic weight management in eligible patients.
  • Mounjaro (tirzepatide): A dual GIP and GLP-1 receptor agonist, Mounjaro has shown excellent efficacy for both blood sugar control and significant weight loss.
  • Saxenda (liraglutide): Another GLP-1 receptor agonist, Saxenda is a daily injectable medication approved for chronic weight management.

How to get a weight-loss prescription online in The Hague, Netherlands

Getting a prescription for approved weight-loss medication through Hi-Doctor is a straightforward and secure process, valid in The Hague and across the EU:

  1. Complete an online questionnaire: Spend 2–3 minutes providing details about your health, medical history, and weight-loss goals.
  2. EU-licensed doctor reviews your case: One of our experienced EU-licensed doctors will individually assess your information to determine if treatment is medically appropriate.
  3. Receive your REMPE prescription in <24 h: If approved, a valid REMPE electronic prescription (a Spanish standard valid EU-wide) will be issued within 24 hours. This is delivered as a downloadable PDF to your private account and by email.
  4. Pick up at any EU pharmacy: Print your prescription or show it on your phone at any pharmacy in any EU country, including the Netherlands, thanks to cross-border prescription directive 2011/24/EU. The online consultation costs a flat €25, and if the doctor finds treatment isn't appropriate, your €25 is automatically refunded – no risk.

Why choose Hi-Doctor over unregulated peptide sellers

When it comes to your health, safety and efficacy are paramount. Hi-Doctor provides a medically sound and regulated pathway to approved weight-loss treatments, unlike the inherent risks of unregulated peptide vendors. We connect you with EU-licensed doctors who perform individual case reviews, ensuring you receive real medications from real pharmacies. Our auditable, RGPD-compliant chat system ensures patient privacy. With over 50,000 patients served and a 4.8 Trustpilot rating, Hi-Doctor offers a trustworthy alternative to 'research chemicals' and grey-market sellers that lack medical oversight and traceability.

Frequently asked questions

Is Retatrutide legal to buy online in Spain?

No, Retatrutide is not legally approved for purchase or prescription in Spain or anywhere in the EU. It is still an investigational drug.

When will Retatrutide be available by prescription?

There is no definitive timeline for Retatrutide's approval. It must successfully complete all clinical trial phases and receive marketing authorisation from regulatory bodies like the EMA, which can take several years.

What's the closest approved alternative to Retatrutide?

While no exact 'triple agonist' alternative is currently approved, Mounjaro (tirzepatide) is a dual GIP and GLP-1 agonist that offers a similar multi-receptor approach and has shown excellent weight-loss efficacy.

How much does an online weight-loss consultation cost?

A consultation with an EU-licensed doctor through Hi-Doctor costs a flat €25. This fee is refunded if the doctor determines treatment is not appropriate for you.

Can I use a Hi-Doctor prescription at any pharmacy?

Yes, Hi-Doctor issues REMPE electronic prescriptions that are valid at ANY pharmacy in any EU country, including the Netherlands, under the cross-border prescription directive 2011/24/EU.

What if I'm not eligible for treatment?

If, after reviewing your questionnaire, our EU-licensed doctor determines that weight-loss treatment is not suitable for your specific health profile, your €25 consultation fee will be automatically refunded.

Does Hi-Doctor offer Retatrutide?

No, Hi-Doctor does not currently offer Retatrutide as it is not yet approved for prescription in the EU.

HI-DOCTOR NEWSLETTER

We'll tell you when we add new treatments.

At most 2 emails a month. No spam. Updates on online health, EU telemedicine, and clinical guides signed by licensed doctors.